We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
674.00 | 5.94% | 12,026.00 | 12,006.00 | 12,012.00 | 12,096.00 | 11,850.00 | 11,890.00 | 4,650,557 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.26 | 186.15B |
Date | Subject | Author | Discuss |
---|---|---|---|
01/1/2023 12:23 | AstraZeneca AB Vaxzevria These are multidose vials which contain 8 doses or 10 doses of 0.5 ml per vial (see section 6.5). One dose (0.5 ml) contains: Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S) * , not less than 2.5 × 108 infectious units (Inf.U) *Produced in genetically modified human embryonic kidney (HEK) 293 cells and by recombinant DNA technology. This product contains genetically modified organisms (GMOs). Excipient with known effect Each dose (0.5 ml) contains approximately 2 mg of ethanol. For the full list of excipients, see section 6.1. | jimarilo | |
01/1/2023 11:49 | AstraZeneca Background on the safety concern ........SOME CASES HAD A FATAL OUTCOME !! Vaxzevria is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older. A combination of thrombosis and thrombocytopenia, in some cases accompanied by bleeding, has been observed very rarely following vaccination with Vaxzevria. This includes severe cases presenting as venous thrombosis, including unusual sites such as cerebral venous sinus thrombosis, splanchnic vein thrombosis, as well as arterial thrombosis, concomitant with thrombocytopenia. The majority of these cases occurred within the first fourteen days following vaccination and occurred mostly in women under 60 years of age. SOME CASES HAD A FATAL OUTCOME. So far, the reported cases occurred after administration of the first dose of Vaxzevria. Experience of exposure to the second dose is still limited. | jimarilo | |
30/12/2022 10:19 | Possible only if you buy the winning ticket... | diku | |
28/12/2022 20:10 | I am hoping to win the lottery, is that possible? | stevie wunderbar | |
28/12/2022 13:18 | I’m hoping the share price will go up to 120.is that possible? | hopefuldave | |
21/12/2022 12:32 | Is this share price accident waiting to happen?...5 years of bull run... | diku | |
20/12/2022 18:02 | You know santa isn't real right? | riskonricky | |
19/12/2022 20:04 | Please keep up to date with your vaccines so I can get my £10.06 per shot. | angus mcoatup | |
19/12/2022 19:36 | "Practices should be aware that the item of Service fee for winter Covid booster programme has been reduced to £10.06 in line with other vaccine programmes" | angus mcoatup | |
19/12/2022 07:43 | Plenty of news this morning from AZN. | hotfinance14 | |
18/12/2022 00:56 | Had Covid jab number four last week, Pfizer flavour this time. | philanderer | |
17/12/2022 22:11 | The Vax injured will have their day. | angus mcoatup | |
17/12/2022 22:02 | AZN boss knighted. Nothing to see here. | angus mcoatup | |
16/12/2022 11:59 | respiratory tract infections will swamp NHS this winter, how can covid vaccination concerns be overblown? long covid protection should be main priority/concerns more jabs should be available to lower age groups & kids my neighbor has lost three members of his family with c19 3000 US deaths reported in last wk alone deaths in China now back over 5000 a day many related to covid 1/1/23 prof Aris Katzourakis In the next couple of months China will experience a billion coronavirus infections many of which will be unvaccinated | mike24 | |
08/12/2022 11:59 | Up again and again | mj19 | |
05/12/2022 21:57 | You know when these brokers fall over each other with higher price targets that is a signal of top coming or already reached?...Pharmas, Miners and Oilys keeping the 3 tier FTSE afloat...the rest of sectors in no mans lala land... | diku | |
05/12/2022 16:32 | Bank of America raises AstraZeneca price target to 14,500 (12,500) pence - 'buy' | philanderer | |
16/11/2022 08:21 | Thank goodness we have full fact.We can trust them. hTTps://fullfact.org | aidenabettin | |
15/11/2022 14:06 | LBBW raises AstraZeneca price target to 12,000 (11,500) pence - 'buy' Stifel raises AstraZeneca price target to 13,300 (12,300) pence - 'buy' | philanderer | |
15/11/2022 10:23 | Good for you - now go away! Suet | suetballs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions